5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5°C, 500 ns), random seed #1
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5°C, 500 ns), random seed #1.
应用场景：
创建时间：
2025-03-11
相关数据集
table1_Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?.docx
Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can
NIAID Data Ecosystem100
Predictors of Acute Kidney Injury in Patients Prescribed Immune Checkpoint Inhibitor Therapy and Their Association with Death: A Systematic Review and Meta-Analysis
Immune checkpoint inhibitors (ICIs) are a novel and promising anti-cancer therapy. We conducted this systematic review to precisely quantify the occurrence and development for actue kidney injury(AKI)
Taylor & Francis Group2025-12-04 更新60
Figure 2: Epitope Maps and confusion matrix with BM5 Ab Crystal inputs
One of AbEMap's applications is to map epitope on a given antigen crystal structure if the antibody structure (bound or unbound) is known. The results in this dataset are pdb files of the 40 antigens
DataCite Commons2025-05-01 更新80
Crystal structure of a ternary complex between PSA, a substrat-acyl intermediate and an activating antibody
Crystal structure of a ternary complex between PSA, a substrat-acyl intermediate and an activating antibody Descriptor: KGISSQY, Prostate-specific antigen, alpha-D-mannopyranose-(1-4)-2-acetamido-2-de
Protein Data Bank Japan2024-10-30 更新60
